presence < present < presentation

Facettes : Author.f AffPays.f AffOrg.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 66.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000009 (2008)	Misato Hashizume [Japon] ; Masahiko Mihara [Japon]	Influence of humanized anti-IL-6R antibody, tocilizumab on the activity of soluble gp130, natural inhibitor of IL-6 signaling
000024 (2012)	A. Finet [France] ; M. Amini-Adle [France] ; B. Balme [France] ; F. Colson [France] ; L. Thomas [France]	Nodular progression of lentigo malignant melanoma during a treatment with tocilizumab: cause or coincidence?
000030 (2010)	Katja Perdan-Pirkmajer [Slovénie] ; Sonja Praprotnik [Slovénie] ; Matija Tomši [Slovénie]	A case of refractory adult-onset Still’s disease successfully controlled with tocilizumab and a review of the literature
000047 (2012)	N. Schütz [Allemagne] ; E. M Rker-Hermann [Allemagne]	Rheumatoide Arthritis und multiples Myelom als Komorbidität
000048 (2012)	Hiroki Wakabayashi [Japon] ; Masahiro Hasegawa [Japon] ; Yosuke Nishioka [Japon] ; Yukari Minami [Japon] ; Kusuki Nishioka [Japon] ; Akihiro Sudo [Japon]	Clinical outcome in patients with rheumatoid arthritis switched to tocilizumab after etanercept or infliximab failure
000051 (2008)	Atsushi Taga [Japon] ; Soichiro Kita ; Kaori Nishiura [Japon] ; Tomonori Hayashi [Japon] ; Mitsuhiro Kinoshita ; Atsushi Sato [Japon] ; Kentaro Suzuki [Japon] ; Shuji Kodama [Japon] ; Kazuaki Kakehi	Analysis of an antibody pharmaceutical, tocilizumab, by capillary electrophoresis using a carboxylated capillary
000055 (2012)	Metin I K [Turquie] ; Levent K L Ç [Turquie] ; Smail Do An [Turquie] ; Meral Çalgüneri [Turquie]	Tocilizumab for giant cell arteritis: an amazing result
000058 (2014)	Lucie M. Turcotte [États-Unis] ; Colleen K. Correll ; Robyn C. Reed ; Christopher L. Moertel	Sustained remission of severe multicentric castleman disease following multiagent chemotherapy and tocilizumab maintenance
000068 (2012)	Yee Chiu [Royaume-Uni] ; Andrew J. K. Ostor [Royaume-Uni] ; Anthony Hammond [Royaume-Uni] ; Katharina Sokoll [Royaume-Uni] ; Marina Anderson [Royaume-Uni] ; Maya Buch [Royaume-Uni] ; Michael R. Ehrenstein [Royaume-Uni] ; Patrick Gordon [Royaume-Uni] ; Sophia Steer [Royaume-Uni] ; Ian N. Bruce [Royaume-Uni]	Access to the next wave of biologic therapies (Abatacept and Tocilizumab) for the treatment of rheumatoid arthritis in England and Wales
000092 (2009)	Yasuhiko Hirabayashi [Japon] ; Tomonori Ishii [Japon] ; Hideo Harigae [Japon]	Clinical efficacy of tocilizumab in patients with active rheumatoid arthritis in real clinical practice
000117 (2010)	C. B. Confavreux [France] ; R. D. Chapurlat [France]	Systemic bone effects of biologic therapies in rheumatoid arthritis and ankylosing spondylitis
000144 (2012)	U. Lange [Allemagne] ; U. Müller-Ladner [Allemagne]	Potenzielle rheumatologische Medikamentenwechselwirkungen im Alter
000149 (2010)	J. Wollenhaupt [Allemagne] ; K. Krüger [Allemagne]	Nicht-TNF-Biologika in der Therapiestrategie bei rheumatoider Arthritis
000161 (2013)	I. Kötter [Allemagne] ; J. C. Henes [Allemagne]	Etablierte Medikamente
000172 (2011)	Maneesh Gogia [États-Unis] ; Daniel E. Furst [États-Unis]	Rheumatoid arthritis and pregnancy: Disease activity, pregnancy outcomes, and treatment options during pregnancy and lactation
000178 (2010)	G. Dückers [Allemagne] ; T. Niehues [Allemagne]	Die Bedeutung von Biologika bei der Therapie der SoJIA (Morbus Still)
000179 (2009)	Masahiko Mihara [Japon] ; Yoshiyuki Ohsugi [Japon] ; Tadamitsu Kishimoto	Evidence for the role of Th17 cell inhibition in the prevention of autoimmune diseases by anti‐interluekin‐6 receptor antibody
000180 (2009)	Guangjie Chen [République populaire de Chine]	Immunotherapy of Rheumatoid Arthritis Targeting Inflammatory Cytokines and Autoreactive T Cells
000181 (2015)	Yi Zhang [États-Unis] ; Xiaohui Wei [États-Unis] ; Gaurav Bajaj [États-Unis] ; Jeffrey S. Barrett [États-Unis] ; Bernd Meibohm [États-Unis] ; Amita Joshi [États-Unis] ; Manish Gupta [États-Unis]	Challenges and considerations for development of therapeutic proteins in pediatric patients
000282 (2010)	Gert Hein [Allemagne] ; Thorsten Eidner [Allemagne] ; Peter Oelzner [Allemagne] ; Michael Rose [Allemagne] ; Alexander Wilke [Allemagne] ; Gunter Wolf [Allemagne] ; Sybille Franke [Allemagne]	Influence of Rituximab on markers of bone remodeling in patients with rheumatoid arthritis: a prospective open-label pilot study
000298 (2012)	Yin Liu [États-Unis] ; Yuval Ramot [Israël] ; Antonio Torrelo [Espagne] ; Amy S. Paller [États-Unis] ; Nuo Si [République populaire de Chine] ; Sofia Babay [Israël] ; Peter W. Kim [États-Unis] ; Afzal Sheikh [États-Unis] ; Chyi-Chia Richard Lee [États-Unis] ; Yongqing Chen [États-Unis] ; Angel Vera [Espagne] ; Xue Zhang [République populaire de Chine] ; Raphaela Goldbach-Mansky [États-Unis, Israël] ; Abraham Zlotogorski [Israël]	Mutations in proteasome subunit β type 8 cause chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature with evidence of genetic and phenotypic heterogeneity

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "present" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "present" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    present
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021